Search Results - "Cardinale, Sandro"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone by Pilli, Tania, Cardinale, Sandro, Cantara, Silvia, Dalmazio, Gilda, Forleo, Raffaella, Capezzone, Marco, Bassi, Cristian, Negrini, Massimo, Ferracin, Manuela, Castagna, Maria Grazia

    Published in Endocrine (01-07-2021)
    “…Purpose Conventional (CONV) treatment of adrenal insufficiency (AI) is associated with risk of overtreatment: glyco-metabolic impairment, bone loss, and…”
    Get full text
    Journal Article
  2. 2

    Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis by Cantara, Silvia, Marzocchi, Carlotta, Pilli, Tania, Cardinale, Sandro, Forleo, Raffaella, Castagna, Maria Grazia, Pacini, Furio

    “…Fine needle aspiration cytology (FNAC) represents the gold standard for determining the nature of thyroid nodules. It is a reliable method with good…”
    Get full text
    Journal Article
  3. 3

    Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population by Cantara, Silvia, Pilli, Tania, Sebastiani, Guido, Cevenini, Gabriele, Busonero, Giulia, Cardinale, Sandro, Dotta, Francesco, Pacini, Furio

    “…Context: MicroRNA (miRNAs) are nonprotein-encoding RNAs that regulate gene expression and enable the distinction of benign from malignant tissues in human…”
    Get full text
    Journal Article
  4. 4

    Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients by Pilli, Tania, Cantara, Silvia, Marzocchi, Carlotta, Cardinale, Sandro, Santini, Chiara, Cevenini, Gabriele, Pacini, Furio

    Published in Thyroid (New York, N.Y.) (01-08-2017)
    “…It has recently been demonstrated that the combination of miRNA-190 and -95 (expressed as probability of malignant risk: pmiRNA) in the serum of Caucasian…”
    Get more information
    Journal Article
  5. 5